Rxcurve
HCPCS J9037 · per 0.5 MG

Inj belantamab mafodot blmf

This code is not in the latest file (4Q26). It was last listed in 1Q23.

Payment limit per 0.5 MG, by effective quarter, 2Q21 to 1Q23. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9037

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
1Q23 $45.278 +$1.033 0.5 MG Inj belantamab mafodot blmf v1, posted December 6, 2023
4Q22 $44.245 +$0.111 0.5 MG Inj belantamab mafodot blmf v1, posted June 22, 2023
3Q22 $44.134 +$0.976 0.5 MG Inj belantamab mafodot blmf v1, posted June 9, 2023
2Q22 $43.158 −$0.13 0.5 MG Inj belantamab mafodot blmf v1, posted December 14, 2022
1Q22 $43.288 +$0.51 0.5 MG Inj belantamab mafodot blmf v1, posted June 8, 2022
4Q21 $42.778 −$0.131 0.5 MG Inj belantamab mafodont blmf v1, posted June 2, 2022
3Q21 $42.909 −$0.065 0.5 MG Inj belantamab mafodont blmf v1, posted June 2, 2022
2Q21 $42.974 – 0.5 MG Inj belantamab mafodont blmf v1, posted March 1, 2022

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files